China Medicine Corporation reported positive results from a third party feasibility report on a product in development, recombinant Aflatoxin Detoxifizyme (rADTZ), a food and feed additive directed at detoxifying aflatoxin (AFT). rADTZ is a potential cancer causing agent. The report was produced by the Feed Research Institute of the Chinese Academy of Agricultural Sciences. More details...

Stock Symbol: (OTCBB: CHME)